Skip to main content
Canadian Pharmacists Journal : CPJ logoLink to Canadian Pharmacists Journal : CPJ
. 2012 Nov;145(6):247. doi: 10.3821/145.6.cpj247

Supreme Court of Canada to hear pharmacy challenges to Ontario ban on private-label generics

Kathie Lynas
PMCID: PMC3567598  PMID: 23509580

The legal fight between the Ontario government and 2 pharmacy chains over generic drug regulations is heading to Canada's highest court.

In a ruling on August 30, 2012, the Supreme Court of Canada revealed its decision to hear 2 appeals on the issue — one from Shoppers Drug Mart and the other from the owners of the Rexall chain, the Katz Group of Companies.

The battle between the 2 companies and the Ontario government dates back to 2010, when the province implemented new generic drug regulations, that among other measures, banned pharmacies from selling their own private-label generic drugs. The province maintained private-label generics would reduce competitiveness and drive up prices.

Shoppers and the Katz Group launched a legal challenge before the Ontario Divisional Court and they won the first round. In February 2011, the court ruled that the province went too far with the ban on store-brand generics. That ruling was overturned by the Ontario Court of Appeal, which ruled in favour of the provincial government in December 2011 — restoring the prohibition on private-label generic drug products.

The Supreme Court of Canada is expected to hear the appeals in May 2013.


Articles from Canadian Pharmacists Journal : CPJ are provided here courtesy of University of Toronto Press

RESOURCES